Biological Material Analysis TRIZ Cases

Fluorescent antibody probes bind CD45RA and CD3 markers to enumerate lymphocytes, removing the need for complex side scatter hardware in point-of-care devices.

Multifunctional placeholder templates resolve template occlusion and heterogeneous binding sites, yielding high-affinity polymers for industrial applications.

Modified anti-PD-L1 antibody CDR sequences block immunosuppressive PD-L1 effects, resolving incomplete immune evasion in cancer treatment.

Monoclonal antibodies with defined CDR sequences bind orthopoxvirus antigens to enable reliable detection and treatment.

MEDI4736 blocks B7-H1 receptors to enhance immune response, reducing tumor size and toxicity.

A rapid test reagent containing HPV-specific antigens detects antibodies in body fluid specimens through a measurable color reaction.

A composite polymer particle maintains uniform diameter during centrifugal separation by minimizing deformation through specific thermal properties.

Knocking out endogenous mouse receptors while inserting human genes resolves modeling inaccuracies for therapeutic antibody assessment.

Collagen IV binds collagen VII to enable antibody-based quantification in biological samples.

Anti-IgM antibody suppresses non-specific reactions from complex AIM, improving measurement precision for free AIM detection.

Mass spectrometry detects and quantifies transgenic proteins directly from crude plant extracts without purification.

A pregnancy test kit uses dual-affinity binding zones to correlate color intensity with human chorionic gonadotropin concentration.

A test kit uses enzyme-conjugated antibodies to detect luteinizing hormone peaks in biological samples.

Isotope-labeled internal standards enable LC-MS/MS detection of parathyroid hormone-related peptide at 0.5 pmol/L.

Local quality and parameter changes enable pH-sensitive binding to reduce autoimmune side effects.

Novel cysteine-reactive linker achieves uniform drug-to-antibody ratios, resolving heterogeneity in AXL-targeting antibody-drug conjugates.

Anti-PD-L1 antibodies bind programmed death-ligand 1 to block inhibitory signaling.

A multiplexed diagnostic system detects parathyroid hormone variants using specific recognition elements to quantify concentrations in clinical samples.

Anti-idiotypic scFv fusion proteins detect therapeutic drug antibodies while excluding autoantibodies and rheumatoid factors from the assay.

DNA aptamers isolate target proteins from complex mixtures, eliminating cross-reactivity with homologous contaminants.

Colloidal gold nanoparticles conjugated to latex microspheres enhance signal intensity in lateral flow assays.

A blood coagulation test reagent containing FXIa and tissue factor measures thrombin generation in biological samples.

Phage-selected human scFv antibodies inhibit c-Met signaling to treat erlotinib-resistant cancers.

Segmented immunoassays use specific antibodies to eliminate cross-reactivity with nutritional supplements.

Antibodies bind to DNA-RNA hybrids in biological samples to resolve insufficient sensitivity in traditional HPV detection methods.

Amphipathic acryloyl copolymers replace detergents and scaffold proteins, enabling detergent-free membrane protein extraction with high stability.

A tumor-specific monoclonal antibody binds exclusively to CD146 on cancer cells, enabling precise detection without affecting vascular integrity.

Long rigid linker molecules position binding partners away from particle surfaces to increase extension length.

Universal antibodies enable single-reagent quantification across species, eliminating separate assays.

Pre-configured multi-color flow cytometry panels quantify non-T cell impurities by eliminating manual antibody titration steps to ensure batch consistency.

An antibody-mediated capture carrier isolates target substances from serum, reducing background interference during lectin-based glycan analysis.

Multi-amine buffers suppress nonspecific reactions in sandwich immunoassays, reducing measurement deviations and improving accuracy.

An inflatable figurine pregnancy indicator resolves ambiguous test line interpretation by combining physical expansion with auditory confirmation.

Monoclonal anti-CD137 agonist antibodies resolve limited T cell activation by binding specific epitopes to enhance cytolytic activity.

Targeting the conserved S2 subunit overcomes variant escape risks associated with variable S1 regions, ensuring broad immune coverage.

Nano-biomimetic mem-transformers mimic acetylcholinesterase structures to identify neurological disorders through high-sensitivity energy sensing.

Optimized LAL binding sites resolve suboptimal native regulator expression to boost polyketide yields.

Modified anti-CD47 antibodies block the CD47/SIRP-alpha interaction to promote tumor cell phagocytosis without causing red blood cell agglutination.

A monoclonal antibody binds to fucosylated AFP glycopeptides using hybridoma technology.

Monoclonal antibodies target the M2-1 viral antigen to enable rapid diagnostic recognition of respiratory syncytial virus in biological samples.

Immunoassays detect DSG-3 protein levels in lymph node samples to identify tumor metastasis with high sensitivity.

Nanogold-labeled monoclonal antibodies enable rapid one-step detection of diacetoxyscirpenol on a nitrocellulose membrane test strip.

An electrochemical immunosensing device detects Zika virus using interdigitated electrodes functionalized with binding ligands.

Acid pre-treatment dissociates IL-33 complexes from ST2 receptors, while blocking agents prevent reformation to reduce assay interference.

Fluorescent labeled antigens bind to secreted monoclonal antibodies on hybridoma surfaces, replacing slow ELISA steps with rapid FACS sorting.

Mesenchymal stem cells reduce systemic inflammation and improve vaccine efficacy by resolving chronic inflammatory dysregulation in elderly subjects.